Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Yoshiya Horimoto

A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience

scientific article published on 05 April 2020

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

article

Elucidation of inhibitory effects on metastatic sentinel lymph nodes of breast cancer during One-Step Nucleic Acid Amplification.

scientific article

Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene Amplification

scientific article published on 01 September 2019

High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer

scientific article published on 22 June 2020

Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer

scientific article published on 13 September 2019

Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up

scientific article published on 27 July 2020

Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer

scientific article published on 24 May 2020

Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer

scientific article published on 27 February 2020

Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer

scientific article published on 08 March 2018

Some pathological and clinical factors are important to describe association between Ki67 expression and recurrences in breast cancer patients receiving neoadjuvant chemotherapy-reply

scientific article published on 09 June 2017

Paulina is supported by:

About Paulina

Help